HOME
About
Team
Our Legacy
NanoSuperheroes
Contact

MEDSAi, PBC

MEDSAi, PBCMEDSAi, PBCMEDSAi, PBC
HOME
About
Team
Our Legacy
NanoSuperheroes
Contact
More
  • HOME
  • About
  • Team
  • Our Legacy
  • NanoSuperheroes
  • Contact

MEDSAi, PBC

MEDSAi, PBCMEDSAi, PBCMEDSAi, PBC
  • HOME
  • About
  • Team
  • Our Legacy
  • NanoSuperheroes
  • Contact

team

Laura Maiorano, President/Co-Founder, Former VP Sales, Managed $650M Sales, Cardinal Health - $225B

 Cardinal Health WIN Co-Founderr and Former VP Solution Sales, Managed $650M in Sales, Cardinal Health, $225B Revenue.  Rehired by Cardinal Health for longstanding reputation of building and developing high performance teams in acute healthcare market.  


Laura has benn instrumental in the development of the EduPal Robot and the Emotion AI for CHOC and Rady Children's Hospitals.  Laura's lifetime experience with children having psychology challenges helped our team design MindHeart AI to benefit children. •

Awarded Cardinal VP of the Year and 

National Winner Integrated Services 

Leadership Award.

•A Co-Founder, Women’s Initiative Council 

Dr. Behnam Bavarian, PhD, CTO/Co-Founder, Professor, Ran UCI's AI & Robot Lab

  - Lead Professor for AI & Robot Dept UCI - VP Security Motorola, “Father of Modern-Day Biometrics” PEAK Anxiety - Deeloped & Oversaw USA's Biometric Security Entry For 12 Countries.'

 Professional Summary

Technology executive, scientist, and innovator with extensive leadership experience in biometrics, artificial intelligence, robotics, neuroscience, public safety systems, and advanced healthcare technologies. Currently serves as CEO  President of AFIS and Biometrics Consulting Inc., providing consulting and strategic support to state, local, and federal criminal justice and public safety agencies. emotional wellness, and healthcare interaction.

Previously held executive leadership roles at Motorola and Motorola Biometrics, overseeing business operations, international expansion, strategic partnerships, R&D, product development, marketing, financial management, and innovation in biometric identification and public safety technologies across government and enterprise sectors.

Additional AI, Robotics & Research Contributions

  • Research and development involving artificial intelligence, emotional AI systems, neural-network-related technologies, biometrics, and advanced robotics platforms 
  • Contributed to development of EduPal, an emotionally intelligent robot designed to help children through engagement, motivational learning, communication, and emotional support 
  • Worked with children’s hospitals and healthcare-focused organizations to explore robotics and AI applications for pediatric care and emotional wellness 
  • Helped develop robotic healthcare technologies focused on autism support, anxiety reduction, depression support, emotional engagement, and pain management 
  • Supported development of AI-driven systems designed to improve patient interaction, emotional recognition, and healthcare communication 
  • Participated in neuroscience and RNA-related research contributing to understanding of brain function, neuronal communication, synaptic plasticity, and neurodevelopmental disorders 
  • Published and contributed to scientific research related to neuronal RNA transport, live-cell imaging, Fragile X Syndrome, autism-related pathways, and neural signaling mechanisms 
  • Experience integrating robotics, AI, computer vision, biometrics, and healthcare technologies into next-generation educational and healthcare platforms 
  • Focused on creating emotionally supportive robotic systems for c


Dr. Jason Dictenberg, PhD, Chief Meds Scientist/Co-Founder, Alzheimers Discovery/Drugs Awards

 Albert Einstein Scholar & Inter. Society of Developmental Neuroscience Awards - ASD & RNA Biology, PEAK Anxiety    

Professional Summary
A  neuroscientist and molecular biology researcher known for his work in neuronal RNA transport, synaptic plasticity, Fragile X Syndrome, autism-related pathways, and live-cell RNA imaging technologies. His research focuses on how messenger RNA (mRNA) moves within neurons and how these processes influence brain development, learning, memory, and neurological disease.

Alzheimer’s Drug, Disease & Neurological Research Contributions

  • Advisory Board Member associated with the Alzheimer's Drug Discovery Foundation, supporting innovation and advancement in neurological and Alzheimer’s-related research initiatives  
  • Research focused on neuronal communication, synaptic plasticity, RNA transport, and molecular mechanisms associated with neurodegenerative and neurological disorders 
  • Published and contributed to scientific work related to Fragile X Syndrome, autism pathways, neuronal signaling, and brain function that may have relevance to Alzheimer’s and neurodegenerative disease research 
  • Experience studying RNA-binding proteins, neuronal mRNA transport, and localized protein synthesis involved in brain health, learning, and memory 
  • Participated in neuroscience research involving live-cell RNA imaging, neural signaling pathways, and synaptic regulation technologies 
  • Involved in development of advanced AI and neuroscience-related technologies that combine emotional AI, biometrics, robotics, and cognitive engagement systems 
  • Helped develop emotionally intelligent robotic systems designed to support cognitive interaction, emotional wellness, anxiety reduction, autism support, depression support, and healthcare engagement for children and seniors 
  • Collaborated on healthcare-focused robotics and AI platforms intended to assist hospitals, caregivers, and pediatric healthcare environments 
  • Research and innovation efforts centered on improving neurological understanding, emotional engagement, patient communication, and future neurotechnology applications in healthcarPotential Relevance to AI & NeurotechnologyUnderstanding neuronal signaling and RNA transport mechanisms may contribute to future AI-assisted neurological diagnostics and therapeutics.

· Research on synaptic plasticity and neuronal communication can inform neurotechnology systems, brain-computer interfaces, and cognitive health applications.

· Live-cell imaging and RNA tracking methods may support future precision medicine and neurodegenerative disease monitoring technologies.

Prepared Summary Based on Published Research & Scientific Literature.

Tony Meador, CEO/Founder, AI Med Board Advisor, UCI & IV Colleges, Apple & Verizon App Awards

Tony Meador, CEO/Founder, AI Med Board Advisor, UCI & IV Colleges, Apple & Verizon App Awards

Tony Meador, CEO/Founder, AI Med Board Advisor, UCI & IV Colleges, Apple & Verizon App Awards

Professional Summary

 AIM Med Advior,, Engineer, VR Animator :- technology Innovation entrepreneur, healthcare innovator, AI architect, and product developer with expertise in mobile technology, artificial intelligence, robotics, healthcare systems, digital payments, entertainment platforms, and advanced medication delivery technologies.

  • · Developed and marketed f the No. 1 Apple App, out of 100 million apps in the Apple App Store, growing the platform to more than 60 million users and earning an Apple Staff Pick Award.
  • · Helped pioneer early-generation mobile applications for major wireless carriers including Verizon, AT&T, and T-Mobile.
  • · Developed mobile mapping, portal, entertainment, ticketing, loyalty, and financial transaction applications during the early growth of the smartphone industry.
  • · Developed highly secure mobile banking and credit card subscription technologies for Sprint.
  • · Developed patented geo-location fraud prevention technology matching mobile device location data with credit card transaction locations to reduce payment fraud.
  • · Integrated banking technologies with major IVR systems and licensed solutions through partnerships to more than 3,000 banks.
  • · Developed mobile movie ticket purchasing systems and hosted APIs used by millions of users through partnerships with Google, Yahoo, and MSN.
  • · Developed QR code ticketing systems with DENSO for major music events and concerts.
  • · Developed one of the first arena mobile applications and early 2D barcode loyalty and ticketing systems.
  • · Launched and sold consumer technology products into more than 10,000 retail stores including Walmart and RadioShack
  • .Former President Noble Labs, grew sales by 40% in two years, managed developmet of automated (pre-0reobotics) powder, liquid and bottle filling machine lines, scqaled to over 1 M unites a month. 
  • · Developed one of the first humanoid robot faces for the Westworld TV show (Information International) and contributed to advanced robotics and futuristic AI-related design concepts associated with entertainment and immersive technologies.
  • · Founder and CEO of MEDS AI, PBC, Inc. focused on AI-driven healthcare, robotics, smart medication systems, and remote dosing technologies.
  • · Led development of MedsPen™ smart remotely dosable medication pen systems for insulin, biologics, rescue medications, and specialty therapeutics
  • · Developed patent-pending MedsPatch™ wearable medication delivery and monitoring systems integrating biometric sensors, remote dosing, and smart therapeutic technologies.
  • · Developed patent-pending MedsToBeds™, D.A.P.P.™, and R.C.A.R.E.™ AI-powered hospital discharge and outpatient medication management ecosystems.
  • · Developed patent-pending MedsPouch™ and PillsTo™ smart medication adherence and compliance systems.
  • · Developed patent-pending AI-driven telehealth, hospital kiosk, smart locker, and remote monitoring platforms.
  • · Contributed to development of EduPal™ and SeniorPal™ emotionally intelligent robotic systems for children, seniors, autism support, mental health, and healthcare engagement.
  • · Contributed to patent and patent-pending innovations involving remote medication dosing systems, wearable therapeutic technologies, and automated medication dispensing systems.
  • · Developed AI-driven healthcare monitoring, triage, predictive analytics, and patient engagement platforms.
  • · Integrated biometrics, CGM technologies, wearable sensors, emotional AI, robotics, and telehealth systems into healthcare platforms.
  • · Developed concepts and systems for medication reversal, emergency intervention, chronic disease management, and hospital-to-home healthcare ecosystems.
  • · Vision focused on combining AI, robotics, biometrics, emotional AI, telehealth, and smart medication technologies to make healthcare smarter, safer, more affordable, and more accessible for hospitals, homecare providers, seniors, children, and chronic disease patients.
  • Mr. Meador has received several patents from the US Patent Office. 


r Rich Geruson, PhD, Economics, Chairman, MedsAI, OpenEmo AI, Former CEO of Microsoft Nuance

Tony Meador, CEO/Founder, AI Med Board Advisor, UCI & IV Colleges, Apple & Verizon App Awards

Tony Meador, CEO/Founder, AI Med Board Advisor, UCI & IV Colleges, Apple & Verizon App Awards

Professional Summary

  • Former CEO $4B Lexmark International, Inc. - 
  • Former CEO Phoenix Technologies, Leading Bios Chips in Most PCs,, Former CIO Nuance Microsoft, Founding CEO VoiceSignal, the Leading Speech & Interactive Voice Technology on Sansung & Motorola Phones.,Acquired by Nuance Microsoft for $200M.
  • Richard Geruson was CEO of the Fortune 500 company Lexmark, the firmware pioneer Phoenix Technologies, and the AI startup VoiceSignal, which invented voice recognition for mobile phones. He also was Senior Vice President at Nokia, Vice President at IBM and Toshiba, and an executive at McKinsey & Co. He has served on 32 boards and 46 advisory boards.
  • Geruson holds three graduate degrees from Oxford University, including a doctorate. He was a visiting scholar at Harvard Business School and earned a master of religion in public life degree from Harvard Divinity School. He is the author of A Theory of Market Strategy (Oxford University Press), which is listed in university syllabi and adopted in business-school curricula worldwide. Other publications include “AI Harms Are Not Ethically Inevitable,” Harvard Divinity Bulletin 53 (3–4, Autumn/Winter 2025). 
  • He currently serves on the Leadership and Business Ethics Council of the Markkula Center for Applied Ethics in Silicon Valley. He delivered the keynote address at the CEO Alliance Summit, and was a CEO Mentor at the Alchemist Accelerator. He received a Finnigan Fellowship from the Commonwealth of Pennsylvania and the Gundaker Fellowship for research at Oxford. He previously served as Board Director of both the Marlboro Symphony Orchestra and Big Brothers Big Sisters of America, Middlesex County.

Eric Goodman, CEO, MVS, Inc. Board, Ronald McDonald Foundation, Over 30 Years Pharma Products

 

Eric Goodman is the Amazon bestselling author of What’s Your Mindset: Mindsets on Life and Leadership. He is also President/CEO of MVS, Inc. (Mountain View Services), a healthcare supply and distribution company serving more than 500 homes for developmentally disabled adults and children for the past 38 years. Eric acquired Chem-Pak, a janitorial and facility supply company, from his father in 2023, making the 38-year-old family business second-generation owned.

He serves/has served on the board of directors for several prominent non-profit organizations, including the American Heart Association, Ronald McDonald House Charities, the Orange County Department of Education Foundation and many more.

MVS, Inc. was a Points of Light The Civic 50 honoree in 2022, 2023, 2024, and 2025, recognized as one of the top 50 most community-minded companies in Orange County. MVS was named the Orange County Business Journal Medium-Sized Family-Owned Business of the Year in 2023, and the Association of Fundraising Professionals, Orange County National Philanthropy Day Outstanding Small Business in 2024. Eric was honored as the Greater Irvine Chamber Philanthropist of the Year in 2024.

Eric has been married to his wife, Roxanne, for 30 years. They have two children, Vanessa and Grant, and one grandchild, Delaney. In additional to his work and family life, Eric holds a passion for photography. His work has appeared in galleries, and all proceeds from his work (newportbeachsunsets.com) are donated to charity.

Dr. Assad Kazeminy, PhD, UCI, Board, UCI Pharmaceutical Science, Founded Irvine Pharmaceutical

 UCI, Board, Pharmaceutical Science Dean’s Leadership Council, founded Irvine Pharmaceutical Services (Acquired) and founded Avrio Biopharmaceutical   

 Dr. Kazeminy founded Irvine Pharmaceutical Services Inc., a premier contract development and manufacturing organization supporting the pharmaceutical, biopharmaceutical, and medical device industries. It served as its Chief Executive Officer from 1988 to October 2016. He founded Avrio Biopharmaceutical LLC, a cGMP contract development and manufacturing organization supporting the pharmaceutical and biopharmaceutical industries from Phase I through post-market life cycle management. He served as its Chief Executive Officer from 2008 to October 2016. Irvine Pharmaceutical Services Inc. and Avrio  Biopharmaceutical LLC were acquired in October 2016 by Nitto Denko Avecia Inc., a recognized leader in therapeutic nucleic acid manufacturing and development services. Dr. Kazeminy served as a United States Pharmacopeia (USP) Expert Committee member from 2000 to 2020 and as a Dean Advisory Panel member at Chapman University School of Pharmacy from 2014-2022. He has been appointed Executive Industry Liaison and Adjunct Professor of Pharmacy at Chapman University School of Pharmacy. 

Dr. Patricia Beckman-Wells, EdD, Producer, Director, Award Winning AI / VR Professor

Rana Gujral, CEO, Behavioral Signals, Voice Emotion, Top Voice AI Influencer, OpenEmoAI Co-Founder

Rana Gujral, CEO, Behavioral Signals, Voice Emotion, Top Voice AI Influencer, OpenEmoAI Co-Founder

•   Depart Head DreamWorks & Disney – Irvine Valley College VR & TV Networks, Author "Face It”

EdD Education

Award Winning Producer

Award Winning AI & VR Animator  

  • Distinguished Educator. Greater Irvine Chamber. ...
  • Commendation, City of Irvine. City Council of the City of Irvine. ...
  • Industry Award: Best Fiction Series. Raw Science film festival. ...
  • Family Tale. Big River Film Festival. ...
  • LunaFest. Clif Bars. ...
  • Animafest Zagreb, FILMS FOR CHILDREN COMPETITION. ...


Rana Gujral, CEO, Behavioral Signals, Voice Emotion, Top Voice AI Influencer, OpenEmoAI Co-Founder

Rana Gujral, CEO, Behavioral Signals, Voice Emotion, Top Voice AI Influencer, OpenEmoAI Co-Founder

Rana Gujral, CEO, Behavioral Signals, Voice Emotion, Top Voice AI Influencer, OpenEmoAI Co-Founder

Rana Gujral builds at the frontier of Artificial Intelligence—AI, Cognitive AI, and the long-horizon path toward AGI. As CEO of Behavioral Signals, he turns advances in speech-signal processing and representation learning into production systems that infer intent, emotion, and risk from voice—powering real-time interaction intelligence, trust & safety, and deepfake detection. His interests span paralinguistics, self-supervised/transformer speech embeddings, Artificial General Experience (AGE), robotics, and cybersecurity. Previously, he founded TiZE (acquired by Alchemy), led Smart Home at Logitech, and drove an innovation-led platform rebuild in consumer tech that returned the business from near-bankruptcy to profitable growth and set the path to its later $4.4B IPO.   

Forthcoming Books

 Rana speaks at the World Economic Forum, The Next Web (TNW), LEAP/DeepFest, CES, WAICF, and TEDx, and writes for TechCrunch and Forbes on applied AI, voice intelligence, leadership, and responsible deployment. Recognition includes Inc.’s “AI Entrepreneur to Watch” and SoundHound’s “Top 40 Voice AI Influencers.”  

The AI Instinct: The Future of Humans and Machine Decision-Making (Wiley, April 2026) 

Anchored Moonshots: A Collection of Heartfelt Essays That Journeyed From Personal Reflection to the Global TEDx Stage (Penguin Random House, Summer 2026).

Advisors & Investors

Neil Sahota, AI Board - United Nations, IBM Watson Master Inventor, Author AI Revolution

Dr Steve Chambers, Ed.L.D, Former President Microsoft Nuance, Former CEO MIT's Jibo AI Robot

Dr Steve Chambers, Ed.L.D, Former President Microsoft Nuance, Former CEO MIT's Jibo AI Robot

•  Former Master Inventor IBM Watson 

Author AI Revolution Best Seller 

UCI Chief Of Innovation

 

Dr Steve Chambers, Ed.L.D, Former President Microsoft Nuance, Former CEO MIT's Jibo AI Robot

Dr Steve Chambers, Ed.L.D, Former President Microsoft Nuance, Former CEO MIT's Jibo AI Robot

Dr Steve Chambers, Ed.L.D, Former President Microsoft Nuance, Former CEO MIT's Jibo AI Robot

•Former CEO Jibo Robot 

Former CMO, helped grow Nuance to Voice Tech Leader / 80% Share Of Hospitals and President Nuance / Microsoft

Andy Ritkin, Renown Robot & AI Inventor & Engineer, Former Developer First Humanoid Robots "Sophia"

•Former CTO Mattel, 

Former CTO, Hanson Robotics,

Developed Many of Mattel's & Hansen's Robots, Yoda Robot, Einstein Robot, And Many Humanoid Robots including the famous and first robot news host Sophia. . 

Dr. Digvijay Singh, Ph.D., Former President Tech Coast Angels, Invented Successful Healthcare AI Co.

Decades tech/AI Expert, UCLA Health, Qualcomm, Intel, Early Investor  

Invented AI Healthcare Products 

  • About
  • Team
  • Our Legacy
  • NanoSuperheroes
  • Contact

Med AI, PBC, Inc.

Copyright © 2026 Meds AI,PBC - All Rights Reserved.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept